BlueStem Wealth Partners’s Boston Scientific BSX Stock Holding History

BlueStem Wealth Partners’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.1M	Buy	17,556 +49	+0.3%	+$3.92K	0.12%	60
2025 Q4	$1.67M	Sell	17,507 -273	-2%	-$26.8K	0.18%	49
2025 Q3	$1.74M	Sell	17,780 -212	-1%	-$22K	0.2%	42
2025 Q2	$1.93M	Buy	17,992 +1,704	+10%	+$172K	0.24%	38
2025 Q1	$1.64M	Sell	16,288 -356	-2%	-$35.8K	0.22%	37
2024 Q4	$1.49M	Buy	+16,644	New	+$1.47M	0.2%	42

Other funds holding BSX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

BlueStem Wealth Partners's BSX Position: Q1 2026 in Review

BlueStem Wealth Partners increased its Boston Scientific (BSX) stake by 0.28% in Q1 2026, buying an estimated $3.92K and bringing the position to 17,556 shares worth $1.1M. The position accounts for 0.12% of the portfolio, ranked #60.

BlueStem Wealth Partners first reported a position in BSX in Q4 2024 and has held it in 6 quarters since. The position peaked at $1.93M in Q2 2025. 1,665 funds tracked by Wall St. Rank hold BSX as of Q1 2026.

BlueStem Wealth Partners held 17,556 shares of Boston Scientific worth $1.1M as of Q1 2026.
BlueStem Wealth Partners bought 49 Boston Scientific shares in Q1 2026, an estimated $3.92K.
Boston Scientific made up 0.12% of BlueStem Wealth Partners's portfolio in Q1 2026, its #60 holding.
BlueStem Wealth Partners first reported a position in Boston Scientific in Q4 2024 and has held it in 6 quarters since.
BlueStem Wealth Partners's Boston Scientific position peaked at $1.93M in Q2 2025.
1,665 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2026.

Based on BlueStem Wealth Partners's 13F filing for Q1 2026, filed 7 May 2026.